CSP #63 – Determining Cyber Risk Appetite With the Board – Adel Melek

Full Audio

View Show Index

Segments

1. Determining Cyber Risk Appetite With the Board – Adel Melek – CSP #63

Sponsored By

Cybereason

Guest

Adel Melek
Deloitte LLP

Adel Melek is Deloitte’s Global Vice Chairman of Risk Advisory, Global Lead Services Partner for Manulife as well as the Global Lead Services Partner for Royal Bank of Canada (RBC). Adel also serves as the Senior Partner responsible for Deloitte’s Tilt to Asia; an initiative designed to effectively serve Deloitte’s largest Canadian corporations seeking to expand their presence in Asia and large Asian clients looking to do the same in Canada.

Adel has over 25 years of diversified professional services experience serving large and complex global organizations on matters related to strategic transformation, large scale technology implementations and integrations, strategic and operational risk, cyber security, IT controls, financial risk, and regulatory compliance. His Deloitte international experience includes advising clients in over 50 countries. Adel served as the Advisory Partner for several iconic Canadian clients including Manulife between 2011-2014.

Host

Vice President, Cybersecurity Strategy at Cybersecurity Collaborative

Todd Fitzgerald has built information Fortune 500/large company security programs for 20 years. Todd serves as VP, Cybersecurity Strategy and Chairman of the Cybersecurity Collaborative Executive Committee, was named 2016–17 Chicago CISO of the Year, ranked Top 50 Information Security Executive, authored 4 books including #1 Best Selling and 2020 CANON Hall of Fame Winner CISO COMPASS: Navigating Cybersecurity Leadership Challenges with Insights from Pioneers (2019), ground-breaking CISO Leadership: Essential Principles for Success, as well as contributions to a dozen others. Todd held senior leadership positions at Northern Trust, Grant Thornton International, Ltd, ManpowerGroup, WellPoint (Anthem) Blue Cross Blue Shield/ National Government Services, Zeneca/Syngenta, IMS Health and American Airlines.